190 related articles for article (PubMed ID: 23197862)
1. A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure Evaluation of Stem Cells study.
Schiavetta A; Maione C; Botti C; Marino G; Lillo S; Garrone A; Lanza L; Pagliari S; Silvestroni A; Signoriello G; Sica V; Cobellis G
Stem Cells Transl Med; 2012 Jul; 1(7):572-8. PubMed ID: 23197862
[TBL] [Abstract][Full Text] [Related]
2. Effect of autologous transplantation of bone marrow cells concentrated with the MarrowXpress system in patients with critical limb ischemia.
Maione C; Botti C; Coppola CA; Silvestroni C; Lillo S; Schiavone V; Sica G; Sica V; Kumar V; Cobellis G
Transplant Proc; 2013; 45(1):402-6. PubMed ID: 23375329
[TBL] [Abstract][Full Text] [Related]
3. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia.
Powell RJ; Comerota AJ; Berceli SA; Guzman R; Henry TD; Tzeng E; Velazquez O; Marston WA; Bartel RL; Longcore A; Stern T; Watling S
J Vasc Surg; 2011 Oct; 54(4):1032-41. PubMed ID: 21684715
[TBL] [Abstract][Full Text] [Related]
4. Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia.
Iafrati MD; Hallett JW; Geils G; Pearl G; Lumsden A; Peden E; Bandyk D; Vijayaraghava KS; Radhakrishnan R; Ascher E; Hingorani A; Roddy S
J Vasc Surg; 2011 Dec; 54(6):1650-8. PubMed ID: 22019148
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia.
Losordo DW; Kibbe MR; Mendelsohn F; Marston W; Driver VR; Sharafuddin M; Teodorescu V; Wiechmann BN; Thompson C; Kraiss L; Carman T; Dohad S; Huang P; Junge CE; Story K; Weistroffer T; Thorne TM; Millay M; Runyon JP; Schainfeld R;
Circ Cardiovasc Interv; 2012 Dec; 5(6):821-30. PubMed ID: 23192920
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.
Murphy MP; Lawson JH; Rapp BM; Dalsing MC; Klein J; Wilson MG; Hutchins GD; March KL
J Vasc Surg; 2011 Jun; 53(6):1565-74.e1. PubMed ID: 21514773
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia.
Madaric J; Klepanec A; Valachovicova M; Mistrik M; Bucova M; Olejarova I; Necpal R; Madaricova T; Paulis L; Vulev I
Stem Cell Res Ther; 2016 Aug; 7(1):116. PubMed ID: 27530339
[TBL] [Abstract][Full Text] [Related]
8. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).
Amann B; Lüdemann C; Rückert R; Lawall H; Liesenfeld B; Schneider M; Schmidt-Lucke J
Vasa; 2008 Nov; 37(4):319-25. PubMed ID: 19003741
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow mononuclear cell therapy for critical limb ischemia is effective and durable.
Liang TW; Jester A; Motaganahalli RL; Wilson MG; G'Sell P; Akingba GA; Fajardo A; Murphy MP
J Vasc Surg; 2016 Jun; 63(6):1541-5. PubMed ID: 27021379
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.
Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM
Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760
[TBL] [Abstract][Full Text] [Related]
12. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
Gabr H; Hedayet A; Imam U; Nasser M
Exp Clin Transplant; 2011 Jun; 9(3):197-202. PubMed ID: 21649569
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia.
Sprengers RW; Moll FL; Teraa M; Verhaar MC;
J Vasc Surg; 2010 Jun; 51(6):1564-8. PubMed ID: 20488328
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot.
Procházka V; Gumulec J; Chmelová J; Klement P; Klement GL; Jonszta T; Czerný D; Krajca J
Vnitr Lek; 2009 Mar; 55(3):173-8. PubMed ID: 19378841
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow stem cell transplantation in critical limb ischemia: a meta-analysis of randomized controlled trials.
Liu FP; Dong JJ; Sun SJ; Gao WY; Zhang ZW; Zhou XJ; Yang L; Zhao JY; Yao JM; Liu M; Liao L
Chin Med J (Engl); 2012 Dec; 125(23):4296-300. PubMed ID: 23217403
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia.
Lara-Hernandez R; Lozano-Vilardell P; Blanes P; Torreguitart-Mirada N; Galmés A; Besalduch J
Ann Vasc Surg; 2010 Feb; 24(2):287-94. PubMed ID: 20142004
[TBL] [Abstract][Full Text] [Related]
17. Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial.
Ohtake T; Mochida Y; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Higashide S; Ioji T; Fujita Y; Kawamoto A; Fukushima M; Kobayashi S
Stem Cells Transl Med; 2018 Nov; 7(11):774-782. PubMed ID: 30059194
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia.
Napoli C; Farzati B; Sica V; Iannuzzi E; Coppola G; Silvestroni A; Balestrieri ML; Florio A; Matarazzo A
Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):709-18. PubMed ID: 19050436
[TBL] [Abstract][Full Text] [Related]
19. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
Gu Y; Zhang J; Qi L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.
Aoyama N; Nishinari M; Ohtani S; Kanai A; Noda C; Hirata M; Miyamoto A; Watanabe M; Minamino T; Izumi T; Ako J
Heart Vessels; 2017 Sep; 32(9):1099-1108. PubMed ID: 28357515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
